These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 19036523)

  • 1. The use of oral ribavirin in the management of La Crosse viral infections.
    Haddow AD; Haddow AD
    Med Hypotheses; 2009 Feb; 72(2):190-2. PubMed ID: 19036523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Periodic lateralized epileptiform discharges in La Crosse encephalitis, a worrisome subgroup: clinical presentation, electroencephalogram (EEG) patterns, and long-term neurologic outcome.
    de los Reyes EC; McJunkin JE; Glauser TA; Tomsho M; O'Neal J
    J Child Neurol; 2008 Feb; 23(2):167-72. PubMed ID: 18160548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. La Crosse encephalitis: occurrence of disease and control in a suburban area.
    Thompson WH; Gundersen CB
    Prog Clin Biol Res; 1983; 123():225-36. PubMed ID: 6867036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of severe La Crosse encephalitis with intravenous ribavirin following diagnosis by brain biopsy.
    McJunkin JE; Khan R; de los Reyes EC; Parsons DL; Minnich LL; Ashley RG; Tsai TF
    Pediatrics; 1997 Feb; 99(2):261-7. PubMed ID: 9024460
    [No Abstract]   [Full Text] [Related]  

  • 5. Newly recognized focus of La Crosse encephalitis in Tennessee.
    Jones TF; Craig AS; Nasci RS; Patterson LE; Erwin PC; Gerhardt RR; Ussery XT; Schaffner W
    Clin Infect Dis; 1999 Jan; 28(1):93-7. PubMed ID: 10028077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and pharmacokinetics of ribavirin for the treatment of la crosse encephalitis.
    McJunkin JE; Nahata MC; De Los Reyes EC; Hunt WG; Caceres M; Khan RR; Chebib MG; Taravath S; Minnich LL; Carr R; Welch CA; Whitley RJ
    Pediatr Infect Dis J; 2011 Oct; 30(10):860-5. PubMed ID: 21544005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serological survey and active surveillance for La Crosse virus infections among children in Tennessee.
    Jones TF; Erwin PC; Craig AS; Baker P; Touhey KE; Patterson LE; Schaffner W
    Clin Infect Dis; 2000 Nov; 31(5):1284-7. PubMed ID: 11073765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe La Crosse encephalitis with significant neurologic sequelae.
    Balkhy HH; Schreiber JR
    Pediatr Infect Dis J; 2000 Jan; 19(1):77-80. PubMed ID: 10643856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. La Crosse encephalitis presenting like herpes simplex encephalitis in an immunocompromised adult.
    Wurtz R; Paleologos N
    Clin Infect Dis; 2000 Oct; 31(4):1113-4. PubMed ID: 11049801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic and social impacts of La Crosse encephalitis in western North Carolina.
    Utz JT; Apperson CS; MacCormack JN; Salyers M; Dietz EJ; McPherson JT
    Am J Trop Med Hyg; 2003 Nov; 69(5):509-18. PubMed ID: 14695088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. La Crosse and other forms of California encephalitis.
    Rust RS; Thompson WH; Matthews CG; Beaty BJ; Chun RW
    J Child Neurol; 1999 Jan; 14(1):1-14. PubMed ID: 10025535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of La Crosse virus inhibition by ribavirin.
    Cassidy LF; Patterson JL
    Antimicrob Agents Chemother; 1989 Nov; 33(11):2009-11. PubMed ID: 2610511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. California-La Crosse encephalitis.
    McJunkin JE; Khan RR; Tsai TF
    Infect Dis Clin North Am; 1998 Mar; 12(1):83-93. PubMed ID: 9494831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical comparisons of La Crosse encephalitis and enteroviral central nervous system infections in a pediatric population: 2001 surveillance in East Tennessee.
    Hardin SG; Erwin PC; Patterson L; New D; Graber C; Halford SK
    Am J Infect Control; 2003 Dec; 31(8):508-10. PubMed ID: 14647115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible congenital infection with La Crosse encephalitis virus--West Virginia, 2006-2007.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Jan; 58(1):4-7. PubMed ID: 19145220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. La Crosse Encephalitis: An Adult Case Series.
    Teleron AL; Rose BK; Williams DM; Kemper SE; McJunkin JE
    Am J Med; 2016 Aug; 129(8):881-4. PubMed ID: 27086496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized, controlled trial of oral ribavirin for Japanese encephalitis in children in Uttar Pradesh, India.
    Kumar R; Tripathi P; Baranwal M; Singh S; Tripathi S; Banerjee G
    Clin Infect Dis; 2009 Feb; 48(4):400-6. PubMed ID: 19143532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double Crossed: A Case of La Crosse Encephalitis.
    Ding A; Shen B; Elliott S; Joshi K; Coghlin D; McLaughlin S
    R I Med J (2013); 2020 Apr; 103(3):59-62. PubMed ID: 32236166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of La Crosse (California encephalitis) virus antigen in mouse skin samples.
    Beaty BJ; Hildreth SW; Blenden DC; Casals J
    Am J Vet Res; 1982 Apr; 43(4):684-7. PubMed ID: 7073091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Ionophores Active against La Crosse Virus Identified through Rapid Antiviral Screening.
    Sandler ZJ; Firpo MR; Omoba OS; Vu MN; Menachery VD; Mounce BC
    Antimicrob Agents Chemother; 2020 May; 64(6):. PubMed ID: 32284379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.